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Abstract
Background: Metarhizium anisopliae is a naturally occurring fungal pathogen of mosquitoes. Recently,Metarhizium
has been engineered to act against malaria by directly killing the disease agent within mosquito vectors and also
effectively blocking onward transmission. It has been proposed that efforts should be made to minimize the virulence
of the fungal pathogen, in order to slow the development of resistant mosquitoes following an actual deployment.
Results: Two mathematical models were developed and analysed to examine the efficacy of the fungal pathogen.
It was found that, in many plausible scenarios, the best effects are achieved with a reduced or minimal pathogen
virulence, even if the likelihood of resistance to the fungus is negligible. The results for both models depend on the
interplay between two main effects: the ability of the fungus to reduce the mosquito population, and the ability of
fungus-infected mosquitoes to compete for resources with non-fungus-infected mosquitoes.
Conclusions: The results indicate that there is no obvious choice of virulence for engineeredMetarhizium or similar
pathogens, and that all available information regarding the population ecology of the combined mosquito-fungus
system should be carefully considered. The models provide a basic framework for examination of anti-malarial
mosquito pathogens that should be extended and improved as new laboratory and field data become available.
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Background
The major route of malaria transmission to humans is
via blood feeding of female Anophelesmosquitoes (princi-
pally Anopheles gambiae and Anopheles funestus). There-
fore, major efforts have been made to control mosquito
populations in areas where malaria is prevalent. When
first introduced, chemical insecticides were very efficient
at reducing malaria prevalence in humans, although not
without environmental damage. However, resistance has
been observed to develop rapidly to broadly-used insec-
ticides and there is a lack of new chemical agents [1,2].
For this reason, fungal entomopathogens have been under
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extensive investigation as alternatives for mosquito con-
trol [3,4]. Diverse fungal pathogens of mosquitoes exist
in nature and additionally can be genetically modified to
generate desirable properties.
The focus of this paper is the application of engineered
fungal pathogens of mosquitoes that can neutralize or kill
malarial sporozoites in themosquito vector itself, prevent-
ing onward transmission to humans. This is motivated
by the recent development of an engineered (Metarhiz-
ium anisopliae) fungus strain [5].Metarhizium is a natural
parasite of mosquitoes that infects through direct con-
tact with the insect cuticle, and therefore is appropriate
for control strategies based on local spraying indoors or
baited traps. Recombinant strains of Metarhizium have
been designed to (i) block attachment of malarial sporo-
zoites to salivary glands of the mosquito; and (ii) neu-
tralize or kill Plasmodium falciparum directly within the
© 2014 Konrad et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Konrad et al. Malaria Journal 2014, 13:11 Page 2 of 10
http://www.malariajournal.com/content/13/1/11
mosquito hemolymph. Under laboratory conditions, these
engineered pathogens were found to substantially reduce
sporozoite counts in the salivary glands of mosquitoes,
compared to both fungus-uninfected mosquitoes and
wild-type Metarhizium [5]. This raises the possibility of
producing a biological agent which targets the malaria
parasite within the mosquito, and is thus able to dis-
rupt the transmission cycle and reduce the prevalence of
malaria in humans.
Interestingly, because fungal pathogens such as
Metarhizium don’t kill infected mosquitoes until their
later life-stages, after the majority of mosquito reproduc-
tion has occurred, it is believed that the selection pressure
for mosquito resistance is quite low and therefore resis-
tance should develop slowly even under widespread
deployment [6]. Mosquito resistance to fungal biopes-
ticides of this type has not been reported to date.
Nonetheless, the concern of emerging resistance leads
Fang et al. [5] to argue against engineering Metarhizium
to kill mosquitoes faster. This argument stands in contrast
to a strategy where fungal species are applied in con-
junction with chemical pesticides to reduce the overall
numbers of mosquitoes (discussed in [3]).
However, even in the absence of developing resistance,
an interesting question remains about how to optimize
Metarhizium or similar agents in terms of virulence
against mosquitoes: should one expect a high virulence
agent to outperform an alternative low-virulence strain?
Indeed, if a high-virulence mosquito pathogen strain has
worse performance than a low-virulence strain even in
the absence of resistance, the threat of resistance addi-
tionally counts against it. (In this context, performance
is measured in terms of reducing human malaria preva-
lence.) This paper presents simple mathematical models
to investigate this question. It will be shown that the
optimal choice of virulence level is not obvious, and
depends quite sensitively on the details of the complex
ecological system. In certain circumstances, it is expected
to be preferable to apply a low-virulence agent which
penetrates the mosquito population, and is thus able to
reduce the prevalence of malaria parasites in mosquitoes
and humans, even though the overall population level of
mosquitoes is not strongly impacted. Under other cir-
cumstances, a high-virulence fungus that more effectively
reduces the total mosquito population is expected to be
preferable.
Mathematical modelling has been used in the study
of malaria and as a tool for evaluating possible con-
trol strategies for over a century. The first mathemati-
cal models for malaria transmission were pioneered by
Ross in 1911 [7] and developed further by Macdonald
[8] and Anderson and May [9]. More recent mathemat-
ical models distinguish between exposed and infectious
humans and mosquitoes reflect the fact that humans
can become (temporarily) immune, treated or vaccinated,
allow spatial heterogeneity, or include time-dependent
parameters to account for environmental factors such as
rainfall and humidity (see for example [10-13]). The cur-
rent paper presents results from simple models for this
new agent and potential improvements for future work are
described.
Methods
Two prototype mathematical models are proposed that
take into account the most fundamental properties of the
malaria parasite, transmission between human host and
mosquito vector, and the fungal mosquito pathogen. To
derive the models in a simple form, it is necessary to make
a number of simplifying assumptions. These assump-
tions could be relaxed in future versions of the model,
at the expense of analytical and intuitive understanding
of the model results. Some possibilities for this work are
described in the conclusions.
Simplified model set-up and assumptions
1. The total human population, H, is taken to be
constant. This is roughly equivalent to supposing
that the population dynamics of mosquitoes, malaria
parasites and fungal pathogens equilibrate rapidly
compared to the human demographic timescale.
The (time-dependent) fraction of humans that are
able to infect mosquitoes with the malaria parasite is
denoted by h(t) and these patients leave the infected
group at rate ρ (for instance due to treatment,
recovery or death). The human population is taken to
be homogeneous in all other ways and the incubation
period in the human host is assumed to be negligible
compared to the duration of infectiousness.
2. The mosquito population is represented in three
parts: uninfected (susceptible), infected with the
malaria parasite, and fungus-infected. These three
populations are denoted by S(t), I(t), and F(t),
respectively. It is necessary to make some simplifying
assumptions concerning the population dynamics of
mosquitoes, with and without the malaria parasite or
the fungal pathogen. A commonly simplified model
for biological populations is that of logistic growth
[14]. This model has been applied in several previous
works on malaria [12,15-17]. Here, it is assumed that,
in the absence of the malaria parasite and the fungus,
the mosquito population experiences logistic growth
with innate growth rate κ˜ and carrying capacity P˜.
All mosquitoes also suffer a natural background
death with rate denoted by μ, which is assumed to be
independent of infection with the malaria parasite
[18]. An alternative model of mosquito population
dynamics, that includes larval and adult stages, is
described below.
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3. It is assumed that every mosquito has a human biting
rate of β , irrespective of its infection status, and that
if the human host is infectious, the bite always
transmits the malaria parasite to the mosquito. On
the other hand if an infected mosquito bites an
uninfected human, the human will develop
transmissible malaria with probability γ .
4. The fungal pathogen is constantly applied to the
environment, and causes mosquitoes to transition
from the S and I classes to the F class continuously,
at constant rate α.
5. The fungal virulence (additional death of mosquitos
due to fungal infection) is denoted by σ . To explicitly
compare the natural mosquito death rate μ with the
fungal virulence σ , one may rewrite the classical
logistic growth equation dS/dt = κ˜S(1 − S/P˜) in the
form presented below, where κ = κ˜ + μ and
P = P˜κ/(κ − μ).
6. The fungus is assumed to be perfectly, permanently
and immediately effective at blocking malaria
parasite transmission to and from fungus-infected
mosquitoes.
Under these assumptions, the following system of ordi-





H (1 − h) − ρh,
dS
dt = κ (S + I + F)
(
1 − S + I + FP
)
− βSh − (μ + α)S,
dI
dt = βSh − (μ + α)I,
dF
dt = α(S + I) − (μ + σ)F .
(1)
A model schematic is given in Figure 1a.
Life-stage-structured mosquito model and assumptions
Recent field studies strongly indicate that mosquito pop-
ulations are controlled via density-dependent regulation
at the larval stage of development [19,20]. The simplified
model above was derived under the assumption that these
effects can be captured via a logistic model for the adult
mosquito population, since the larval population is not
modelled explicitly. This simplification allows for fairly
clean analytical results, but the biological system may
have been oversimplified. Additionally, vertical transmis-
sion is a feature of certain fungal symbionts of insects [21].
Therefore, a possible improvement of the engineered fun-
gus would be a vertically transmissible variant, that could
be passed from mosquitoes to their offspring. To accom-



















































Figure 1Model schematics. a. Simplified model. The fraction of
infected humans in the population is given by h. Infection of
susceptible mosquitoes S occurs at mass-action rate β while
removal/recovery occurs at a rate ρ . Infected mosquitoes I infect
susceptible humans with probability γ , given an encounter. Malaria
infection does not significantly alter the mosquito death rate μ, but
fungus infection, occurring with rate α reflecting the intensity of
fungal application, increases the death rate by σ . Since neither
malaria nor the fungus is transmitted vertically in the simplified
model all new-born mosquitoes (indicated by κ) are susceptible.
b. Life-stage structured model. In this model mosquitoes produce
larvae at rate κc . Larvae may be fungal carriers (LF ) or fungus-free (LS)
and undergo density-dependent competition (see text) with intensity
parameter κL . Larvae mature to produce adult mosquitoes at ratem.
The parameter ξ determines the degree of vertical transmissibility of
the fungal pathogen.
resources, and to consider vertical transmission, an alter-
nativemodel is now put forward. Thismodel is built under
the following set of additional assumptions:
1. Adult mosquitoes produce new larvae at a constant
rate κc, irrespective of infections with fungus or
malaria parasites. The offspring of fungal-infected
mosquitoes are themselves infected with probability
ξ , representing the probability of vertical
transmission of the fungal pathogen. The
populations of fungus-uninfected and
fungus-infected larvae are denoted by LS(t) and LF(t)
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respectively. In the absence of information about
larval infectibility, it is assumed that larvae are not
directly infected by the fungus (although they may be
infected via vertical transmission), and that the
fungus has no detrimental effects in the larval stage.
2. Larvae compete for resources in a density-dependent
manner, with the intensity of competition
determined by the parameter κL.
3. Larvae mature into adult mosquitoes at rate m. In
contrast to the simplified model, adult mosquitoes do
not directly compete for resources.
Under these additional assumptions, a new life-stage-
structured model can be put forward:
dh




dt = κc(S + I + (1 − ξ)F) − κL (LS + LF) LS − mLS
dLF
dt = κcξF − κL (LS + LF) LF − mLF
dS
dt = mLS − βSh − (μ + α)S
dI
dt = βSh − (μ + α)I
dF
dt = mLF + α(S + I) − (μ + σ)F
(2)
A model schematic is given in Figure 1b.
Results and discussion
The goal is now to study the level of malaria in humans
(h) as a function of the fungal parameters: the spraying
rate α, fungal virulence σ and fungal vertical transmissi-
bility ξ . For the simplified model, analytical results will be
presented and applied to find the optimal values of α and
σ in terms of reducing malaria in humans. For the life-
stage-structuredmodel, the situation is more complex and
results will be shown only for particular numerical values
of the parameters. In both models, it is found that appli-
cation of a highly virulent fungus as biopesticide may not
be the best strategy.
The simplified model with no fungus
If there is no fungus present in the system, the simplified




H (1 − h) − ρh,
dS
dt = κ (S + I)
(
1 − S + IP
)
− βSh − μS,
dI
dt = βSh − μI.
(3)
This system has three relevant equilibria: (1) the triv-
ial equilibrium (h, S, I) = (0, 0, 0) (no mosquitoes, no
malaria); (2) the malaria-free equilibrium (h, S, I) =
(0, (1 − μ
κ








β2γP(κ − μ) − Hκμρ




From the malaria-free equilibrium it is observed that
κ > μ is the basic requirement for there to be mos-
quitoes in the system. This corresponds to the basic
mosquito growth rate κ being large enough to outweigh
mosquito death (and with no mosquitoes there can be no
malaria).
The key quantity determining whether malaria will exist
in the system is the basic reproduction number for the
no-fungus system, R(NF)0 = β
√
γ Sm/(ρμH), where Sm =
P(1 − μ
κ
) is the mosquito population at the malaria-
free steady state. This quantity can be calculated using
the next-generation method [22]. The square root occurs
in this formula because there are two steps per rounds
of transmission, mosquito to human to mosquito, and
the next-generation R0 is, by definition, a per-step quan-
tity. The parameter β is not included in the square root
because it determines the transmissibility human-vector
and vector-human. It can also be shown that if R(NF)0 < 1
then the malaria-free equilibrium is locally stable and the
endemic equilibrium does not exist, while if R(NF)0 > 1
then the endemic equilibrium exists and is locally stable.
Equilibrium analysis of the simplified model
The simplified model including the fungus (1) supports
three distinctive equilibria, which can be defined as the
trivial,malaria-free and endemic equilibria. The following
results on the local stability of these equilibria can then
be proven (see Additional file 1 for the proofs, which are
lengthy but straightforward):
1. The trivial equilibrium (h, S, I, F) = (0, 0, 0, 0) is
locally asymptotically stable if and only if
κ <
(μ+α)(μ+σ)
μ+α+σ . This condition is analogous to the
condition κ > μ for the model with no fungus,
described above.
2. The malaria-free equilibrium
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exists in the positive plane and is locally
asymptotically stable if and only if both of the
following conditions are fulfilled:
κ >
(μ + α)(μ + σ)
μ + α + σ and R0 = β
√
γ Sm
ρ(μ + α)H < 1.
The first condition corresponds to the survival of the
mosquito population (exactly as for the trivial
equilibrium). The second condition states that the
basic reproductive number for malaria, R0, must be
subcritical.
3. The endemic equilibrium

















exists in the positive plane and is locally
asymptotically stable if and only if both of the
following conditions are fulfilled:
κ >
(μ + α)(μ + σ)
μ + α + σ and R0 = β
√
γ Sm
ρ(μ + α)H > 1.
By comparing R0 for the simplified model to the equiva-
lent no-fungus quantity (R(NF)0 ), it is possible to see the role
of the spraying rate α in reducing the reproductive num-
ber of the malaria parasite. The virulence of the fungus
(parameter σ ) does not affect R0, because it is assumed
that mosquitoes that are infected with the fungus are not
able to transmit the malaria parasite.
Optimizing the virulence and application of the fungal
pathogen in the simplified model
The two parameters of the model that are in principle
under control in a real application are α (the applica-
tion/spraying rate) and σ (the parameter controlling fun-
gal virulence). Our goal is to choose α and σ such that the
endemic malaria prevalence in humans
he = he(α, σ) = R
2
0(α, σ) − 1
R20(α, σ) + β/(μ + α)
,
is minimized. The first and most intuitive result is that
he is a monotonic decreasing function of α, which means
that the more the mosquitoes are exposed to the fungus,
the lower the endemic malaria prevalence is in humans.
Increasing the fungus application rate is therefore always
beneficial. This result is numerically illustrated in Figure 2.
It can further be shown (see Additional file 1) that the total
number of mosquitoes (S + I + F) also decreases when α





















































Figure 2 Prevalence of malaria in humans and total number of
mosquitoes for varying fungus deployment rates. The steady
state human malaria prevalence and the total mosquito population,
both relative to baseline, are plotted against the fungus exposure
intensity α, with fixed fungal pathogen virulence σ = 0.1/day. As
expected, quantities decrease when α increases. Note that, once α is
large enough so that R0 < 1 and malaria is eradicated, he remains
constant at 0. Full details of all other chosen parameter values are
given in Additional file 2.
increases, unless the fungal virulence σ is zero, in which
case the total number of mosquitoes is independent of α.
There are two possible effects of continual fungus appli-
cation that have to be considered in answering the ques-
tion of how to find the optimal fungal virulence σ :
1. The biopesticide effect: Increasing the fungal
virulence will lead to a decrease in the total number
of mosquitoes (S + I + F). This can be confirmed
mathematically for the presented models (see
Additional file 1).
2. The competition effect: Fungus-infected mosquitoes
F do not contribute directly to the transmission of
the malaria parasite to humans. However, they do
compete for resources with all the
non-fungus-infected mosquitoes. Therefore, if the
fungal virulence is low, then the population will have
a higher fraction of non-malaria-carrying mosquitoes
and the force of infection of the malaria parasite on
humans could plausibly be reduced.
Hence there is a tradeoff between the two mechanisms
above: the total number of mosquitoes could be mini-
mized by a high-virulence fungus (biopesticide effect), but
what is critical for the prevalence in humans is the total
number of mosquitoes infected with the malaria pathogen
- and this might be minimized (via the competition effect)
by a low-virulence fungus.
In order to determine the balance of these two effects,
one must carefully analyse the mathematical model. It is
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then possible to establish a critical threshold for the rela-
tion between the mosquito innate growth rate κ and the
natural mosquito death rate μ that makes one or the other
argument stronger. Specifically, it can be shown that the
malaria prevalence in the human population he(α, σ) and
the total number of infected mosquitoes Ie(α, σ) are both
maximized if
σ = σ ∗ ≡ (κ − 2μ)2 − κ/(μ + α) .
This result indicates how to best design the fungus: To
avoid the worst case σ = σ ∗, the virulence σ must be
chosen far away from σ ∗.
Note that while σ = σ ∗ maximizes the malaria preva-
lence in humans as well as the total number of malaria-
infected mosquitoes, it does not maximize or minimize
the total number of mosquitoes. This result reveals the
complexity of the tradeoff between the biopesticide and
the competition effect, and indicates the importance of a
good understanding of the mosquito population as well as
the fungus-mosquito interaction, in designing the optimal
pathogen for deployment.
Optimal virulence depends on backgroundmosquito
growth rate
Continuing the analysis of the previous section, two inter-
esting cases can be distinguished: (i) If σ ∗ is negative,
then σ is necessarily greater than σ ∗ and hence vir-
ulence should always be maximized to reduce malaria
prevalence in humans (indicating that the biopesticide
effect is stronger than the competition effect); (ii) If σ ∗
is positive, however, then a very large σ or a very low
σ is desirable, but not an intermediate value. In the sec-
ond case, this shows that the choice is either to use the
fungal pathogen as a biopesticide (high virulence) or a
distributed anti-Plasmodium agent (low virulence) in the
mosquito population.
The choice depends on the relation between the
mosquito growth rate κ , the mosquito death rate μ and
the fungal exposure rate α. If the growth rate κ is small
compared to the mosquito death rate μ (specifically, if
κ < 2μ) then σ ∗ < 0 for any value of α, and hence a
larger fungal virulence σ is always desirable. This means
that the fungus should be used as a biopesticide for slow-
growing mosquito populations. On the other hand, if the
mosquito population is relatively fast-growing (κ > 2μ),
then σ ∗ is negative for 0 < α < (κ − 2μ)/2, while σ ∗ is
positive for α > (κ − 2μ)/2. Parameter estimation (see
Additional file 2) yields that κ ≈ 5μ, implying that in most
real mosquito populations, the latter scenario is much
more realistic. Hence, if the fungus can be applied at a
sufficient rate, then minimizing the fungal virulence σ
has the most beneficial effect of malaria prevalence in
humans.
Figure 3 illustrates these principles for particular param-
eter choices. The human malaria prevalence he(α, σ) is
plotted, relative to the baseline prevalence when no fun-
gus is applied, and hence indicating how malaria man-
agement can be optimized. The left column shows the
slow-growing result (κ < 2μ) where the optimal strat-
egy is to use the fungal pathogen as a biopesticide. The
right column shows the more surprising result where, if
the fungus deployment rate is sufficient, it is preferable to
select a low-virulence fungus strain. In all cases, verifying
the first result of this section, it can be seen that a higher
fungus-exposure rate α is always desirable.
Equilibrium analysis of the life-stage-structured model
The investigation of the simplified model has shown that
depending on the ecology of the mosquito population, it
can be expected that there are circumstances where the
optimal virulence of the fungal pathogen can be zero.
However, competition between mosquitoes in the sim-
plified model takes place in the adult stage, but recent
evidence indicates that competition occurs at the larval
stage. To examine this effect it is necessary to use themore
complex, life-stage-structured model (2), which includes
the larval stage. In this section the effects of vertical
transmission of fungus will also be examined.
Life-stage-structured model without vertical transmission
of fungus
By setting ξ = 0 in the second model, it is possible to
investigate the model without vertical transmission. Sim-
ilar to the simplified model, it can be shown that this
model supports three easily explained equilibria, corre-
sponding to (i) the trivial equilibrium with no mosquitoes
and no malaria, (ii) a malaria-free equilibrium with
mosquitoes but no malaria, and (iii) an endemic equi-
librium state. Provided that the malaria-free equilibrium
with mosquitoes exists, it can be shown that the endemic




β2γm2((κc − μ)(μ + α + σ) − ασ)




ρ(μ + α)H > 1,
where
S0 = m
2 ((κc − μ)(μ + α + σ) − ασ)
κL(μ + α)2(μ + σ)
is the equilibrium number of mosquitoes in the popula-
tion in the absence of the malaria parasite. Under this
condition, the fraction of the human population infected
with malaria, at the endemic equilibrium, is given by the

















































































Figure 3Malaria prevalence in humans varying over fungal pathogen virulence and deployment rate. The heat maps (top row) indicate the
endemic malaria prevalence in humans he , relative to baseline where no fungus is applied, for the given parameters, the graphs (bottom row) show
a one-dimensional projection of the heat maps, for a fixed fungal application (spraying) rate. Two distinct cases can be distinguished: (i) If
κ − 2μ < 0 (left column) then human malaria prevalence is a decreasing function of fungal virulence σ and deployment rate α. (ii) If κ − 2μ > 0
(right column), the curve describing the worst-case fungal virulence σ ∗ is superimposed, indicating a non-monotonic relationship between human
malaria prevalence and σ . Top row: The dark blue region indicates R0 < 1 and hence he = 0. Bottom row: one-dimensional slice through the heat
map above for a fixed value of α = 0.1/day (left) and α = 0.5/day (right), as indicated by the black line in the heat map above. Here, μ = 0.1/day,
while κ = 0.18/day (left) and κ = 0.48/day (right). All other parameter values are as given in Additional file 2.
same function of R0 as before (reflecting the very similar
structures of the two models),
h(σ ) = R
2
0 − 1
R20 + β/(μ + α)
.
The derivative of this function with respect to σ is found
to have no zeroes and is always negative for R0 > 1. This
indicates that the human prevalence of malaria is a strictly
decreasing function of σ and therefore the best strategy
for the life-stage-structured model with no vertical trans-
mission of fungus is to increase the fungal virulence as
much as possible. This result (illustrated in Figure 4, top
left panel where ξ = 0) stands in contrast to the previous
section wheremore nuanced conclusions were drawn, and
is a consequence of the fact that the competition effect is
occurring at the larval stage, while the biopesticide effect
is occurring at the adult stage. Since it is adult mosquitoes,
not larvae, that act as vectors for the malaria parasite, only
the biopesticide effect can reducemalaria incidence in this
version of the model.
Life-stage-structured model with vertical transmission of
fungus
Vertical transmission is a feature of fungal symbionts of
insects [21] and it seems natural to consider this in the
context of the model. The life-stage-structured model,
where the parameter ξ is the vertical transmission frac-
tion, reflects this possibility and allows the previous anal-
ysis to be repeated. In this case, the analytical expressions
for the steady states of the full model can be obtained
using a computer algebra system, such as Mathematica,
but are too long to usefully give here. However, the basic
analytical results remain: there are three potential equi-
libria of the model, but only one has mosquitoes and
malaria. Further, although the model is resistant to analyt-
ical exploration, it is easy to choose parameters and work
numerically.
Figure 4 shows the equilibrium fraction of infected
humans as a function of the fungal virulence σ and
application rate α, across a range of possible vertical
transmission probabilities ξ . It is observed that if verti-
cal transmission is unlikely then the benefit of the fungus
is maximized by high virulence, but when vertical trans-
mission becomes more likely, an intermediate or low
virulence fungus would be favourable. In fact, in some
cases a highly vertically transmissible fungus (ξ ≥ 0.85 in
Figure 4) is predicted to be able to eliminate malaria alto-
gether, provided the virulence is low, but not too low. In all
cases it should be noted that, as is to be expected, increas-
ing the fungal application rate α is always beneficial.
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Figure 4Malaria prevalence in humans varying over vertical transmission, deployment rate and fungal virulence. Each subfigure shows
the endemic malaria prevalence in humans, relative to the no-fungus baseline, plotted against the fungal virulence σ , for five different levels of the
fungal application (spraying) rate α. The different values of α in each subfigure are {0.05, 0.1, 0.15, 0.2, 0.25} days−1, corresponding to curves from
top to bottom, and the length of the dashing increases with α. Each subfigure represents a different value of the vertical transmissibility ξ from
ξ = 0 (no vertical transmission) to ξ = 1 (perfect vertical transmission). All other parameter values are as given in Additional file 2.
These results indicate how the biopesticide effect of
high virulence, acting at the adult stage, can be dominated
by the competition effect at the larval stage, provided the
adult and larval stages are coupled sufficiently strongly by
vertical transmission of the fungus. In this case, highly vir-
ulent fungus are found to be less effective because they
prevent the fungus-infected mosquitoes from generating
fungus-carrying larvae. This reduces competitive inhibi-
tion of fungus-uninfected larvae, thus reducing the overall
effectiveness of the fungus in preventing malaria parasite
infection of mosquitoes, and so ultimately increasing the
prevalence of malaria in humans.
Conclusions
In this paper, mathematical models have been employed
to investigate the effectiveness of a fungal pathogen that
blocks malaria transmission in mosquitoes to reduce
malaria prevalence in humans. Unsurprisingly, all mod-
els indicate that malaria prevalence in humans could be
reduced substantially by such a counter measure, and
that the mosquito exposure rate to the fungus should
be maximized to reduce malaria prevalence. However,
the main interest of the results is to demonstrate that
the optimal design of an agent that can simultaneously
kill mosquitoes, and malaria parasites within mosquitoes
depends quite sensitively on the details of a complex
ecological system.
The first model, in which competition between
mosquitoes occurred at the adult level, showed that in
fast growing mosquito populations the fungal pathogen
should be engineered to have low virulence. This result
is independent of the possibility of mosquito resistance
developing to the fungal pathogen and can be under-
stood in very simple terms: fungus-infected mosquitoes
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do not directly contribute to the malaria epidemic, but
competitively hamper the introduction/survival of new
susceptible mosquitoes. If mosquito resistance to fun-
gal biopesticides arises in the field, this argument would
additionally be strengthened.
In the second model, competition occurs at the larval
stage of development. This model predicted that, in the
absence of vertical transmission of the fungal pathogen, a
highly virulent (biopesticidal) fungus would be desirable.
However, the addition of reliable vertical transmission to
this model significantly alters the predictions. If the fun-
gal pathogen could be engineered in this way, then a high
virulence would be highly detrimental to its efficacy as an
anti-malarial strategy.
The key observation that should be drawn is that find-
ing the optimal properties of agents that can reduce the
malaria parasite incidence in mosquitoes is not an easy
task, since several direct and indirect effects need to be
parameterized and balanced, leading to conclusions that
depend on the details of the mosquito population, fungal
pathogen, and environment.
In order to obtain a straightforward analytical treat-
ment, several simplifying assumptions were made
throughout. It was assumed that the fungus could com-
pletely block onwardmalaria transmission.Modifying this
assumption in the simplified model leads to an increased
favourability of virulence, but the authors believe that
this issue will best be resolved in a future model where
the time dependence of the fungus-mosquito interac-
tion is explicitly analysed. Also, by assuming a constant
mass-action biting coefficient, human reactions to avoid
mosquito bites (bed nets or indoor residual spraying)
were neglected. This was done to study the pure effect
of the fungus interaction, but is likely not a realistic
representation of a real-life setting. Furthermore, the
human population was modelled as a homogeneous
population, neglecting for example co-infections, age
structure, and previous malaria history. All of the above
have an important impact on the malaria epidemic:
co-infections increase the severity of each disease, chil-
dren are much more vulnerable to malaria, and previous
malaria infections can lead to temporal immunity. The
incubation period of the malaria parasite and of the fun-
gus in mosquitos were also neglected. This simplification
particularly affects the mosquito population, where the
incubation period is of about the same order as the life
expectancy. Future work will include extending the cur-
rent model to add more details of mosquito and malaria
parasite life history in an age- and life-stage-dependent
model of the mosquito.
Horizontal fungal transfer betweenmosquitoes was also
not considered here. This effect has been observed for
a number of fungal symbionts of insects and could play
a role similar to vertical transmission in enhancing the
effectiveness of the fungal pathogen. Horizontal trans-
fer (possibly mediated through the environment) between
mosquitoes would also be expected to increase the effec-
tiveness of fungal spread, and reduce the necessary level
of fungal application/spraying in the environment, which
might otherwise have to be very intense. Further, in
assuming a fairly simple logistic growth model, seasonal
effects such as rainfall and humidity were neglected.
These effects would lead to temporal variations in the
mosquito population growth rate and carrying capacity, as
well as unknown possible effects on the fungal pathogen.
A final topic for possible future work is to consider spa-
tial heterogeneities such as breeding sites and human
habitat.
Despite these limitations, the models are useful in defin-
ing an argument for a minimal virulence of the anti-
malarial fungal pathogens. In future work, as field studies
of Metarhizium or similar agents are completed, the
parameterization of the model can be improved, and new
models that allow insights into the potential of a large-
scale deployment of such controls for malaria and other
mosquito-borne diseases can be developed.
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